SignatureFD’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.07K Hold
168
﹤0.01% 2765
2026
Q1
$4.44K Hold
168
﹤0.01% 2818
2025
Q4
$4.87K Hold
168
﹤0.01% 2702
2025
Q3
$4.67K Buy
168
+30
+22% +$758 ﹤0.01% 2697
2025
Q2
$3.36K Hold
138
﹤0.01% 2721
2025
Q1
$2.87K Hold
138
﹤0.01% 2779
2024
Q4
$3.25K Sell
138
-129
-48% -$3.17K ﹤0.01% 2739
2024
Q3
$6.84K Sell
267
-3,000
-92% -$76.4K ﹤0.01% 2476
2024
Q2
$76.7K Hold
3,267
﹤0.01% 1295
2024
Q1
$94K Hold
3,267
﹤0.01% 1225
2023
Q4
$107K Sell
3,267
-119
-4% -$3.24K ﹤0.01% 1065
2023
Q3
$94.3K Hold
3,386
﹤0.01% 1086
2023
Q2
$115K Sell
3,386
-302
-8% -$9.49K ﹤0.01% 989
2023
Q1
$111K Buy
3,688
+272
+8% +$8.43K ﹤0.01% 991
2022
Q4
$96.4K Hold
3,416
﹤0.01% 1024
2022
Q3
$112K Buy
3,416
+129
+4% +$4.74K ﹤0.01% 902
2022
Q2
$104K Hold
3,287
﹤0.01% 972
2022
Q1
$151K Sell
3,287
-12
-0.4% -$572 ﹤0.01% 838
2021
Q4
$202K Sell
3,299
-80
-2% -$5.53K 0.01% 710
2021
Q3
$252K Buy
3,379
+179
+6% +$15K 0.01% 597
2021
Q2
$296K Buy
3,200
+73
+2% +$6.21K 0.01% 518
2021
Q1
$277K Buy
3,127
+45
+1% +$4.46K 0.01% 476
2020
Q4
$287K Buy
3,082
+20
+0.7% +$1.59K 0.01% 420
2020
Q3
$195K Hold
3,062
0.01% 487
2020
Q2
$160K Buy
3,062
+3,000
+4,839% +$129K 0.01% 525
2020
Q1
$2K Hold
62
﹤0.01% 1897
2019
Q4
$2K Hold
62
﹤0.01% 1853
2019
Q3
$2K Buy
+62
New +$2.02K ﹤0.01% 1783

Other funds holding ARKG

SignatureFD's ARKG Position: Q2 2026 in Review

SignatureFD held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 168 shares worth $7.07K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

SignatureFD first reported a position in ARKG in Q3 2019 and has held it in 28 quarters since. The position peaked at $296K in Q2 2021. 71 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • SignatureFD held 168 shares of ARK Genomic Revolution ETF worth $7.07K as of Q2 2026.
  • SignatureFD left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2765 holding.
  • SignatureFD first reported a position in ARK Genomic Revolution ETF in Q3 2019 and has held it in 28 quarters since.
  • SignatureFD's ARK Genomic Revolution ETF position peaked at $296K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.